Harvard symposium on the clinical efficacy and hemostatic mechanism of action of poly-N-acetyl glucosamine.
Hirsch
Joshua A
JA
Massachusetts General Hospital, Boston, USA.
D000117:Acetylglucosamine / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006487:Hemostasis / Q000187:drug effects*; D006488:Hemostasis, Surgical / Q000295:instrumentation*; D006490:Hemostatics / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D023421:Models, Animal; D011677:Punctures / Q000009:adverse effects; D013523:Surgical Equipment; D016896:Treatment Outcome
D006490:Hemostatics; C113831:poly-N-acetyl glucosamine; D000117:Acetylglucosamine